SCHEMBL28229449

SCHEMBL28229449

O=C(O)OC(=O)c1cc2ccccc2cn1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 1/20 0.48
EGFR P00533 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
PDPK1 O15530 1/20 0.40
DPP4 P27487 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
DRD3 P35462 1/20 0.38
LCK P06239 1/20 0.38
CHRNA7 P36544 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
PLAU P00749 1/20 0.38
PTPN7 P35236 1/20 0.38
MAPT P10636 1/20 0.38
MGAM O43451 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27950633 0.85 EGLN1 (0.43) EGLN1CYP1A2CYP2A6PDPK1DPP4
SCHEMBL9318876 0.82 EGLN1 (0.47) EGLN1EGFRCYP1A2CYP2A6PDPK1
SCHEMBL1658084 0.81 EGLN1 (0.41) EGLN1CYP1A2CYP2A6PDPK1DPP4
SCHEMBL214090 0.81 LCK (0.56) EGLN1CYP1A2CYP2A6LCKMAPT
SCHEMBL29840564 0.81 LCK (0.56) EGLN1CYP1A2CYP2A6LCKMAPT
SCHEMBL29746814 0.80 EGLN1 (0.54) EGLN1EGFRCYP1A2CYP2A6PDPK1
SCHEMBL155043 0.80 EGLN1 (0.54) EGLN1EGFRCYP1A2CYP2A6PDPK1
SCHEMBL29489052 0.80 EGLN1 (0.54) EGLN1EGFRCYP1A2CYP2A6PDPK1
Hydrochloric Acid SCHEMBL27800514 0.79 LCK (0.55) EGLN1CYP1A2CYP2A6LCKMAPT
Water SCHEMBL1201320 0.78 EGLN1 (0.53) EGLN1EGFRCYP1A2CYP2A6PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108341777-A Compound of isobioquin group and its application 四川科伦博泰生物医药股份有限公司 2018-07-31 CN disclosed